40 Speen Street, Suite 102
Framingham, Massachusetts 01701
October 20, 2021
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jessica Ansart
|Re:||Xenetic Biosciences, Inc. Registration Statement on Form S-3 (File No. 333-260201)|
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations promulgated under the Securities Act of 1933, as amended, Xenetic Biosciences, Inc. hereby requests that its Registration Statement on Form S-3 (File No. 333-260201) filed with the Securities and Exchange Commission (the “Commission”) on October 12, 2021, as amended by the pre-effective Amendment No. 1 to Form S-3 filed with the Commission on October 20, 2021, be declared effective by the Commission at 5:00 p.m. Eastern Time on Friday, October 22, 2021, or as soon thereafter as practical.
Once the Registration Statement is declared effective, please orally confirm that event with our counsel, Holland & Knight LLP, by calling Danielle Price at (305) 349-2259.
Thank you for your assistance.
|/s/ James Parslow|
|Chief Financial Officer|